<DOC>
	<DOCNO>NCT01917656</DOCNO>
	<brief_summary>This trial conduct Africa Asia . The aim trial investigate efficacy safety liraglutide versus sulphonylurea ( SU ) combination metformin Ramadan subject type 2 diabetes ( T2DM ) .</brief_summary>
	<brief_title>Efficacy Safety Liraglutide Versus Sulphonylurea Both Combination With Metformin During Ramadan Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects diagnose T2DM treat metformin equal 1000 mg/day SU ( gliclazide , glipizide glyburide/glibenclamide maximum tolerate dose ( least half maximum approve dose ) glimepiride maximum tolerate dose ( least 2 mg/day ) ) , stable dose least 90 day prior screen . Stable define unchanged medication dose HbA1c 7.010.0 % ( 53 86 mmol/mol ) ( inclusive ) Body Mass Index ( BMI ) equal 20 kg/m^2 Subjects express intention fast ( daytime , i.e . sunrise sunset ) Ramadan receive medical counsel regard risk fast Any contraindication successful sustain fast medical perspective discretion investigator ( acute illness , severe hypoglycaemia within 90 day prior screen , history recurrent hypoglycaemia , hypoglycaemia unawareness , ketoacidosis within 90 day prior screen , hyperosmolar hyperglycaemic coma within 90 day prior screen , subject perform intense physical labour ) Any chronic disorder severe disease , opinion investigator might jeopardise subject 's safety compliance protocol History chronic pancreatitis idiopathic acute pancreatitis Screening calcitonin value equal 50 ng/L Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome type 2 ( MEN 2 ) Impaired liver function , define alanine aminotransferase ( ALAT ) equal 2.5 time upper normal limit ( UNL ) Impaired renal function define estimate glomerular filtration rate ( eGFR ) 60 mL/min/1.73 m^2 per Modification Diet Renal Disease ( MDRD ) formula ) Any episode unstable angina , acute coronary event , cerebral stroke/transient ischemic attack ( TIA ) significant cardiovascular event judge investigator within 90 day prior screen Diagnosis malignant neoplasm previous 5 year ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>